Chartwell Partners is honored to have been selected to partner with Allakos on the recruitment of Baird Radford as Chief Financial Officer. Mr. Radford’s experience helping to lead companies through the transition from R&D to commercial stage will be a distinct advantage as Allakos prepares for potential commercialization of its first product candidate. Most recently,…
Month: April 2021
We are delighted to announce the recruitment of Ian Hunt as SVP, Regulatory Affairs for Akebia Therapeutics, a public, Cambridge, MA-based biopharmaceutical company committed to bettering the lives of people impacted by kidney disease. Most recently, Ian served as Vice President and Head of Regulatory Affairs for GSK’s Infectious Disease, Neuroscience and CV/Renal franchises, a…
Chartwell is delighted to have served as executive search partner to Prothena for the Company’s recruitment of its Chief Medical Officer, Hideki Garren, MD, PhD. The breadth and success of Dr. Garren’s neuroscience drug development experience will be distinct advantages as Prothena looks towards the continued development, registration, and commercialization of its first assets. Most…